Optimal CAR T-cell immunotherapy strategies for a leukemia treatment model
In this article, was formulated and solved the optimal control problem with two bounded controls using the Pontryagin maximum principle. A controlled model of CAR T-cell immunotherapy, which describes the dynamics of CAR T-cells, normal or healthy B-cells, cancer cells and cytokines as four ordinary differential equations of the Lotka-Volterra type with two bounded controls. The first is the concentration of injected CAR immune T cells and its effect on system parameters. The second reflects the effect of an immunosuppressant such as tocilizumab and its role in preventing cytokine storms. The authors formulate an optimal control problem to minimize tumor cells and cytokine concentration. Then the Pontryagin maximum principle is applied and the type of optimal controls depending on the switching functions is found. It is revealed that the second optimal control, reflecting the suppressive effect of a possible ``cytokine storm, is constant, taking the maximum value over the entire time interval of the treatment period. Analytically examining the properties of the first switching function, the authors find that the corresponding optimal control takes a maximum value at the end of the time interval. Therefore, the type of the switching function is found, which determines the behavior of the first optimal control responsible for the injection schedule CAR. It turned out that this function has no more than two switches, and that, depending on the parameters of the model, it can accept one of five optimal treatment scenarios. Thus, a controlled model of CAR T-cell immunotherapy was created and the problem of its optimal control was solved.
- Optimal control applied to immunotherapy
- Optimization for the intensive treatment of leukemia
- Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine
- Optimal control in a model of dendritic cell transfection cancer immunotherapy
- The combined effects of optimal control in cancer remission
- A Generalized Estimate of the Number of Zeros for Solutions of a Class of Linear Differential Equations
- A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
- Cancer immunotherapy, mathematical modeling and optimal control
- Determination of the optimal controls for an ebola epidemic model
- scientific article; zbMATH DE number 3167340 (Why is no real title available?)
- scientific article; zbMATH DE number 3204015 (Why is no real title available?)
- scientific article; zbMATH DE number 3249985 (Why is no real title available?)
- scientific article; zbMATH DE number 3256013 (Why is no real title available?)
- Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine
- Optimal control for a SIR epidemic model with nonlinear incidence rate
- Optimal control for an SEIR epidemic model with nonlinear incidence rate
- Optimal control for anticancer therapy
- Optimal controls of the highly active antiretroviral therapy
- Optimal strategies in the treatment of cancers in the Lotka-Volterra mathematical model of competition
- Parametrization of the attainable set for a nonlinear control model of a biochemical process
- Program and positional control strategies for the Lotka-Volterra competition model
- The dynamics of an optimally controlled tumor model: A case study
- The Operator of Translation Along the Trajectories of Differential Equations
- Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine
- Optimal control theory: introduction to the special issue
- Metaheuristics and Pontryagin's minimum principle for optimal therapeutic protocols in cancer immunotherapy: a case study and methods comparison
- Immune therapeutic strategies using optimal controls with \(L^{1}\) and \(L^{2}\) type objectives
- CAR T cells for T-cell leukemias: insights from mathematical models
- An optimal strategy for leukemia therapy: a multi-objective approach
- An optimal treatment strategy for a leukemia immune model governed by reaction-diffusion equations
- Cytokine storm mitigation for exogenous immune agonists
- Extensibility of solutions of nonautonomous systems of quadratic differential equations and their application in optimal control problems
- Understanding the role of B cells in car T-cell therapy in leukemia through a mathematical model
- A mathematical model for cell-cycle non-specific chemotherapy with application to low-grade glioma: an optimal control approach
This page was built for publication: Optimal CAR T-cell immunotherapy strategies for a leukemia treatment model
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2223666)
